These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2905897)

  • 21. [Clinical trial of a new antacid-antiulcer preparation].
    Betti M
    Minerva Med; 1967 Aug; 58(69):2927-34. PubMed ID: 4383470
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

  • 23. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term management of peptic ulcer disease: current role of H2-antagonists.
    Brooks WS
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():47-52. PubMed ID: 1349553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Antihistamines and gastric acid secretion.
    Can Med Assoc J; 1975 Jan; 112(2):131. PubMed ID: 234286
    [No Abstract]   [Full Text] [Related]  

  • 29. Perspectives in Drug Development and Clinical Pharmacology: The Discovery of Histamine H1 and H2 Antagonists.
    Jones AW
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):5-12. PubMed ID: 27119574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histamine H2-receptor antagonists.
    Sewing KF
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):221-6. PubMed ID: 7913
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of surgery in the comparison of peptic ulcer before and after the advent of H2 receptor blockers in the light of our experience].
    Pinto E; Verre L; De Stefano A; Trombì G
    Minerva Chir; 1987 Sep; 42(18):1375-82. PubMed ID: 2892149
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of a new antisecretory and antacid medication].
    Galli L; Bissi A
    Minerva Chir; 1968 May; 23(9):477-82. PubMed ID: 4386093
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: The interaction of cholinergic and histaminic blockades on the partieta cell: therapeutic possibilities.
    Thompson MH; Albinus M; Blair EL; Reed JD; Venables CW
    Br J Surg; 1975 Feb; 62(2):158. PubMed ID: 234769
    [No Abstract]   [Full Text] [Related]  

  • 34. No acid, ulcer--the role of histamine receptor blockers.
    Cocco AE
    Md State Med J; 1978 Oct; 27(10):62-3. PubMed ID: 29996
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [H2 receptor antagonists in the therapy of peptic ulcer disease].
    Dammann HG; Dau B; Dreyer M; Müller P; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of peptic ulcer. H2 receptor blockers].
    Domschke W
    Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness and safety of long-term H2-receptor antagonist maintenance therapy].
    Wormsley KG
    Orv Hetil; 1992 Nov; 133(47):3013-7. PubMed ID: 1359491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC
    Acta Gastroenterol Belg; 1992; 55(5-6):415-22. PubMed ID: 1363166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.